4 completed, 3 not yet recruiting. 7 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Not yet recruiting 3 |
| Phase 1 | 1 | Completed 1 |
Follow Cutis Laxa: new trials by email Literature Review of Cutis Laxa trials Research Report on Cutis Laxa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing Pavise Serum, Sham Comparator, Co2/Er:YAG - Skin Laxity | Phase 2 | Not yet recruiting | Goldman, Butterwick, Fitzpatrick and Groff | 8 | 2026-03-20 | 2026-03-10 |
| Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists Skinvive - Wrinkle | Phase 2 | Not yet recruiting | Goldman, Butterwick, Fitzpatrick and Groff | 24 | 2025-11-01 | 2025-10-28 |
| Assess Impact of Poly-L-lactic Acid on GLP1 Subjects Sculptra Aesthetic - Laxity; Skin | Phase 2 | Not yet recruiting | Goldman, Butterwick, Fitzpatrick and Groff | 20 | 2025-10-27 | 2025-10-16 |
| CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques collagenase clostridium histolyticum - Edematous Fibrosclerotic Panniculopathy, Cellulite | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 35 | 2020-10-01 | 2022-09-28 |
| Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow Sofwave Treatments - Skin Laxity, Wrinkle | Phase 2 | Completed | Sofwave Medical LTD | 93 | 2019-11-20 | 2021-07-22 |
| Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells Laser therapy, Autologous ADSC injection, Normal saline injection - Skin, Scar | Phase 1 / Phase 2 | Completed | Medical University of Warsaw | 100 | 2018-01-31 | 2023-02-01 |
| Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon) XOPH5 Ointment, Placebo - Lower Eyelid Steatoblepharon (Excess Eyelid Fat) | Phase 2 | Completed | Topokine Therapeutics, Inc. | 90 | 2014-09-01 | 2016-02-08 |
Blepharoptosis (1) · Cellulite (1) · Cicatrix (1) · Facies (1) · Keloid (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Connective Tissue Diseases (7) · Genetic Diseases, Inborn (7) · Skin Diseases (7) · Skin Diseases, Genetic (7) · Skin and Connective Tissue Diseases (7) · Pathological Conditions, Signs and Symptoms (3) · Pathologic Processes (2) · Collagen Diseases (1) · Disease Attributes (1) · Eye Diseases (1) · Eyelid Diseases (1) · Fibrosis (1) · Signs and Symptoms (1) · Skin Manifestations (1)
Laser Therapy (1) · Microbial Collagenase (1) · Saline Solution (1)
Goldman, Butterwick, Fitzpatrick and Groff (3) · Endo USA Inc., a Keenova Therapeutics Company (1) · Medical University of Warsaw (1) · Sofwave Medical LTD (1) · Topokine Therapeutics, Inc. (1)
United States (5) · Poland (1)
Avishai Tzur (1) · David Hernandez (1) · Janusz R Jaworowski, PhD (1) · Maria Noszczyk-Kostrzewa, PhD (1) · Michael S. Singer, MD, PhD (1)
2016 (1)